Physician profile
Nandini Raman
NPI 1831157023
$1,509.21
in general payments reported to CMS, 2019-2025
24 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.67 · 2020: $404 · 2021: $247 · 2022: $96.12 · 2023: $180 · 2024: $234 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $361.60 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $180.47 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $156.86 | 2024-2025 | Freestyle Libre 3, Proclaim |
| Astrazeneca Pharmaceuticals LP | $118.01 | 2019-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $116.11 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $76.60 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $53.86 | 2022-2023 | |
| Lucid Diagnostics INC. | $46.86 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.73 | 2021-2025 | Jardiance |
| Astellas Pharma US INC | $40.71 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $38.71 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Nevro Corp. | $35.52 | 2020 | |
| Boston Scientific Corporation | $32.19 | 2025 | Watchman Flx |
| Amarin Pharma, INC. | $27.83 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.35 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20.90 | 2023 | Intellis Adaptivestim |
| Renalytix Ai, INC. | $19.75 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Paratek Pharmaceuticals, INC. | $19.66 | 2024 | Nuzyra |
| Topcon Healthcare Solutions, INC. | $19.54 | 2019 | |
| Grifols USA, LLC | $16.86 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.03 | 2019 | |
| Pfizer INC. | $15.00 | 2020 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Allergan, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nandini Raman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.